Company data
Candel Therapeutics, Inc. employees and revenue per employee
CADL · Biotechnology · $728M market cap
Candel Therapeutics, Inc. had 76 employees at the end of fiscal Dec 2022, up 16.9% from a year earlier. Revenue for the year was $125,000, unchanged from a year earlier, or $2K per employee. Headcount grew faster than revenue.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
76
+16.9% YoY
Revenue
$125,000
+0.0% YoY
Revenue / employee
$2K
Peer median $458K
Rank in industry
108 of 109
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2022 | 76 | $125,000 | $2K | +16.9% | +0.0% |
| Dec 2021 | 65 | $125,000 | $2K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Candel Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| ARTV Artiva Biotherapeutics, Inc. | 89 | $251,000 | $3K | — |
| AVTX Avalo Therapeutics, Inc. | 33 | $59,000 | $2K | Hiring into decline |
| CADL Candel Therapeutics, Inc. | 76 | $125,000 | $2K | Hiring ahead |
Questions about Candel Therapeutics, Inc.
- How many employees does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. reported 76 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 30, 2023. That is up 16.9% from a year earlier.
- What is Candel Therapeutics, Inc.'s revenue per employee?
- Candel Therapeutics, Inc. brought in $125,000 of revenue in fiscal Dec 2022, which is $2K per employee. That ranks 108 of 109 companies we track in Biotechnology, where the median is $458K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare CADL with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Candel Therapeutics, Inc.'s annual reports (Form 10-K), latest filed March 30, 2023. This is data, not a recommendation to buy or sell CADL.